Regine Brokamp
Operationeel Directeur bij Selexis SA
Actieve functies van Regine Brokamp
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Selexis SA
 Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Operationeel Directeur | - | - |
Loopbaan van Regine Brokamp
Eerdere bekende functies van Regine Brokamp
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Max-Planck-Institute for Molecular Genetics | Corporate Officer/Principal | - | - |
Micromet AG
 Micromet AG Pharmaceuticals: MajorHealth Technology Micromet AG developed, manufactured and marketed novel antibody derived therapeutics for the treatment and control of cancer, inflammatory and autoimmune diseases. It's goal was to commercialize products in these indication areas that have significant unmet medical needs. Founded in 1993, the company was headquartered in Munich, Germany. | Corporate Officer/Principal | - | - |
Statistieken
Internationaal
| Duitsland | 3 |
| Zwitserland | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Sectoraal
| Commercial Services | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Commercial Services |
Micromet AG
Micromet AG Pharmaceuticals: MajorHealth Technology Micromet AG developed, manufactured and marketed novel antibody derived therapeutics for the treatment and control of cancer, inflammatory and autoimmune diseases. It's goal was to commercialize products in these indication areas that have significant unmet medical needs. Founded in 1993, the company was headquartered in Munich, Germany. | Health Technology |
- Beurs
- Insiders
- Regine Brokamp
- Ervaring
